Torrent Pharma stock loses 3 per cent on US FDA warning letter
Stock of the drug firm was down 2.61 per cent at Rs 1,622.60 on the BSE
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Torrent Pharmaceuticals
Torrent Pharma gets warning letter from US FDA for Gujarat facility
The company is committed in maintaining the highest standards of compliances and quality manufacturing across all its facilities…
Dr Reddy’s halts worldwide supply of ranitidine
USFDA probing into the reported impurity N-nitrosodimethylamine in it at low levels
Torrent Pharma expands recall of hypertension drug in US
The company is expanding recall for Losartan potassium tablets USP and Losartan potassium / hydrochlorothiazide tablets to the…
Torrent Pharma seeks shareholder approval for equity raise and borrowing plans
The move will help the company to take quick and effective actions to capitalise on opportunities
Torrent Pharma board approves Zyg Pharma’s amalgamation
It will result in concentrated management focus and synergies of operations and facilitating inter transfer of resources and…
Torrent Pharma announces Q4 & FY 2014-15 results
For Q4 FY 2014-15, revenues were at Rs 1,154 crores down by six per cent from Rs 1,225 crores
Ahmedabad-based Torrent…
Torrent to acquire 100 per cent stake in Zyg Pharma
The acquisition will help Torrent to strengthen its position in niche dermatological segment especially in the developed markets…
3 Indian cos receive US FDA nod for 1st generic Abilify to treat mental illnesses
Alembic Pharmaceuticals, Hetero Labs, Teva Pharmaceuticals and Torrent Pharmaceuticals have received FDA approval to market…
Torrent Pharma in agreement with Reliance Life Sciences
Reliance Life Sciences will manufacture these products at its facility in Navi Mumbai and supply to Torrent Pharma for a period of…